Economic Evaluation of a Recombinant Follicle-Stimulating Hormone (Follitropin Beta, Puregon) in Infertile Women Undergoing In Vitro Fertilisation in Greece

Author： van Loon J.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.19, Iss.3, 2000-03, pp. : 201-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant follicle-stimulating hormone: gold standard or not?

By Out Henk J  

Reproductive BioMedicine Online, Vol. 11, Iss. 5, 2005-11 ,pp. : 536-539

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Recombinant human follicle-stimulating hormone: a controversial issue – without controversy

By Shoham Zeev  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 5, 2004-05 ,pp. : 1033-1044

Informa Healthcare

Access to resources Recommend Favorite

Recombinant human follicle-stimulating hormone: a scientific step to clinical improvement

By Hugues J-N  

Reproductive BioMedicine Online, Vol. 2, Iss. 1, 2001-01 ,pp. : 54-64

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Sperm aneuploidies after human recombinant follicle stimulating hormone therapy in infertile males

By Piomboni Paola   Serafini Francesca   Gambera Laura   Musacchio Concetta   Collodel Giulia   Morgante Giuseppe   De Leo Vincenzo  

Reproductive BioMedicine Online, Vol. 18, Iss. 5, 2009-05 ,pp. : 622-629

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Recombinant follicle-stimulating hormone: First report of mesothelial cyst of the round ligament: case report

By  

Reactions Weekly, Vol. 1, Iss. 1034, 2005-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite